SequelSEC

Endovia Health Sciences, Inc. EDVA

Beverages · CIK 0001553788 · Fiscal year ends 1231

AnnualQuarterlyTTM
Revenue
$0
Fiscal year ended 2026-06-30
Operating income
-$2.01M
Fiscal year ended 2026-06-30
Free cash flow
Unavailable
Fiscal year ended 2026-06-30

Endovia Health Sciences, Inc. (EDVA) reported revenue of $0 and net income of -$2.05M for the fiscal year ended 2026-06-30. This page shows 10 annual periods of income statement, balance sheet and cash flow figures normalized from Endovia Health Sciences, Inc.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Beverages.

Income

Endovia Health Sciences, Inc. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-302024-03-31
Revenue$0$4.22K-$365.21K$393.07K-$23.41K$68.61K-$2.77M$981.86K$1.05M$1.54M
Cost of revenueUnavailableUnavailableUnavailable$0$0Unavailable$929.50K$690.84K$802.35K$1.38M
Gross profit$0$1.85K$47.34K-$23.84K-$32.15KUnavailable-$818.86K$291.02K$244.43K$163.62K
Operating income-$2.01M-$978.97K-$976.41K-$9.54M-$1.50M-$1.66M-$289.63K-$2.67M-$3.69M-$3.25M
Net income-$2.05M-$2.14M-$3.21M-$9.89M-$8.49M-$3.65M-$9.04M-$4.72M-$5.33M-$4.67M
Research & developmentUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Weighted-average diluted sharesshares 3.06Mshares 4.57MUnavailableshares 2.19Mshares 474.97Kshares 1.86MUnavailableshares 1.31Mshares 1.23Mshares 1.12M
Pretax incomeUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Income tax expense$0$0$0$0$0$0$0$0$0$0
Diluted EPSUnavailable$-0.47UnavailableUnavailableUnavailable$-1.97UnavailableUnavailableUnavailableUnavailable
Selling, general & administrativeUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
General & administrativeUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable$55.00KUnavailableUnavailable
Selling & marketing$27.25K$17.27K$10.52K$8.83K$12.77K$29.89K-$161.67K$227.92K$214.81K$202.45K

Balance

Endovia Health Sciences, Inc. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-302024-03-31
Cash & equivalents$242.70K$381.20K$281.44K$265.67K$17.21KUnavailable$13.79KUnavailableUnavailable$14.76K
Total assets$1.08M$769.95K$965.69K$22.49M$22.24M$2.51M$2.76M$8.36M$8.06M$8.56M
Current assets$900.41K$708.85K$631.99K$1.97M$1.61M$1.69M$1.90M$3.04M$2.54M$2.84M
Total liabilities$16.83M$16.97M$16.27M$15.71M$13.52M$22.54M$21.39M$19.19M$18.41M$18.06M
Current liabilities$16.83M$16.97M$16.26M$15.64M$13.45M$20.42M$19.37M$17.78M$16.82M$17.02M
Total equity incl. NCI-$15.75M-$16.20M-$15.30M$6.78M-$11.28M-$20.03M-$18.63M-$10.83M-$10.35M-$9.50M
Temporary (mezzanine) equityUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Inventory$54.92K$54.92K$33.54K$855.33K$855.33K$861.05K$319.10K$1.34M$1.31M$1.47M
Accounts receivable$14.32K$20.33K$15.75K$139.50K$140.63K$172.82K$191.99K$595.30K$669.13K$755.90K
GoodwillUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable$256.82K$256.82K$256.82K
Long-term debtUnavailable$857$3.42K$58.13K$52.53K$2.08M$1.97M$1.32M$1.43M$810.17K
Accounts payable$4.09M$4.63M$4.81M$6.75M$7.04M$6.32M$3.59M$5.58M$4.92M$4.95M

Cash flow

Endovia Health Sciences, Inc. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-302024-03-31
Operating cash flow-$1.09M-$930.49K-$991.22K-$2.47M-$551.12K-$808.05K-$919.68K-$2.65M-$2.43M-$1.31M
Capital expendituresUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Investing cash flowUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable$0-$4.74K$1.50K$0
Financing cash flow$1.16M$1.05M$977.84K$2.67M$696.36K$755.81K$1.16M$3.01M$2.42M$950.14K
Net change in cash-$138.49K$99.76K$17.32K$248.45K$17.21K-$15.35K-$230.29K$448.59K-$6.46K-$365.22K
Stock-based compensation$1.11M$176.97K$677.33K$7.75M$53.86K$135.71K$271.01K$186.68K$1.34M$556.67K
Common dividends paidUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Common share repurchasesUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Depreciation & amortizationUnavailable$2.32K-$101.77K$106.41K$2.32K$2.32K-$3.72K$135.06K$135.03K$135.23K

Derived

Endovia Health Sciences, Inc. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-302024-03-31
Free cash flowUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Gross marginUnavailable43.8%Unavailable-6.1%UnavailableUnavailableUnavailable29.6%23.4%10.6%
Operating marginUnavailable-23176.4%Unavailable-2428.2%Unavailable-2417.1%Unavailable-271.9%-352.6%-211.0%
FCF marginUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
SBC / revenueUnavailable4189.7%Unavailable1972.1%Unavailable197.8%Unavailable19.0%128.2%36.1%
Current ratio0.05x0.04x0.04x0.13x0.12x0.08x0.10x0.17x0.15x0.17x
Revenue YoY growthUnavailable-93.8%Unavailable-60.0%-102.2%-95.5%-203.0%-80.9%-79.9%-73.5%
Net marginUnavailableUnavailableUnavailable-2515.1%UnavailableUnavailableUnavailable-480.7%UnavailableUnavailable
R&D / revenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
CapEx / revenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Long-term debt / equityUnavailableUnavailableUnavailable0.01xUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Effective tax rateUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open EDVA in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-19View SEC filing
10-Q · Filed 2026-05-20View SEC filing
10-K · Filed 2026-04-15View SEC filing
10-Q · Filed 2025-11-19View SEC filing
10-Q · Filed 2025-08-14View SEC filing
10-K · Filed 2025-07-11View SEC filing

Companies in the same industry

BF.B BRCC BUDA CIRX COCO CWGL IPST JSDA KDP KO MDWK MOJO

Reconciliation checks needing review

2 periods on this page do not reconcile under this site’s normalization. Read that as a limitation here before an observation about the company: the figures are the filer’s own, the filings linked above are authoritative, and a difference usually means the concepts this site selected do not match how this filer presents its statements. Nothing is adjusted to make a check pass.

gross profit bridgeinconsistent2025-03-31

Withheld: cost revenue could not be reconciled with the rest of this filer’s statement.

balance equationreview2025-06-30

Difference 20000000 exceeds tolerance 1000000. Presentation or filing-vintage differences need review.